ArticleJournal of general internal medicine2017
Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey.
Article in Journal of general internal medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Associations between pharmaceutical industry interactions with physicians and chronic nonmalignant pain management prescribing practices: a systematic review.Cost effectiveness and resource allocation : C/E · 2026Review
- Robotics, money and research: is data or physician payments driving robotic bariatric surgery literature?Surgical endoscopy · 2025Review
- Industry marketing payments to physicians and prescription patterns for sacubitril/valsartan in the USA.Heart (British Cardiac Society) · 2025Article
- Associations between pharmaceutical industry payments to physicians and prescription of PARP inhibitors in the United States.Gynecologic oncology · 2024Article
- Increasing trends of pharmaceutical payments to breast cancer specialists in Japan: A retrospective study from 2016 to 2019.PloS one · 2024Article
- Article
- Article
- Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians.International journal of environmental research and public health · 2022Article
- A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough.Journal of general internal medicine · 2021Article
- Public Awareness of and Personal Willingness to Use California's Extreme Risk Protection Order Law to Prevent Firearm-Related Harm.JAMA health forum · 2021Article
- Open data on industry payments to healthcare providers reveal potential hidden costs to the public.Nature communications · 2019Article
- US Nationwide Disclosure of Industry Payments and Public Trust in Physicians.JAMA network open · 2019Article
- Effect of the public disclosure of industry payments information on patients: results from a population-based natural experiment.BMJ open · 2019Article
- Ophthalmology Patient Perceptions of Open Payments Information.JAMA ophthalmology · 2018Article
- Towards Patient-Centered Conflicts of Interest Policy.International journal of health policy and management · 2018Article
- Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2017Review
- Capsule Commentary on Pham-Kanter et al., Public Awareness of and Contact with Physicians Who Receive Industry Payments: A National Survey.Journal of general internal medicine · 2017Article
- Altruism and Medical Practice.Journal of general internal medicine · 2017Article
- Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Physician Payments Sunshine Act, part of the Affordable Care Act, requires pharmaceutical and medical device firms to report payments they make to physicians and, through its Open Payments program, makes this information publicly available.
objectiveTo establish estimates of the exposure of the American patient population to physicians who accept industry payments, to compare these population-based estimates to physician-based estimates of industry contact, and to investigate Americans' awareness of industry payments.
designCross-sectional survey conducted in late September and early October 2014, with data linkage of respondents' physicians to Open Payments data.
participantsA total of 3542 adults drawn from a large, nationally representative household panel. MAIN MEASURES: Respondents' contact with physicians reported in Open Payments to have received industry payments; respondents' awareness that physicians receive payments from industry and that payment information is publicly available; respondents' knowledge of whether their own physician received industry payments. KEY
resultsAmong the 1987 respondents who could be matched to a specific physician, 65% saw a physician who had received an industry payment during the previous 12 months. This population-based estimate of exposure to industry contact is much higher than physician-based estimates from the same period, which indicate that 41% of physicians received an industry payment. Across the six most frequently visited specialties, patient contact with physicians who had received an industry payment ranged from 60 to 85%; the percentage of physicians with industry contact in these specialties was much lower (35-56%). Only 12% of survey respondents knew that payment information was publicly available, and only 5% knew whether their own doctor had received payments.
conclusionsPatients' contact with physicians who receive industry payments is more prevalent than physician-based measures of industry contact would suggest. Very few Americans know whether their own doctor has received industry payments or are aware that payment information is publicly available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.